CXCR4 and breast carcinoma: This is supported by the data of Boudot group, who detected that NR2F1 stimulated the metastatic cascade via CXCL12/CXCR4 pathway by activating epithelial growth factor (EGF) and EGF receptor in breast cancer [37].